These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11202204)

  • 1. What happens when growth hormone is discontinued at completion of growth? Metabolic aspects.
    Johannsson G
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1321-6. PubMed ID: 11202204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular risk of GH-deficient adolescents.
    Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GH replacement on metabolism and physical performance in GH deficient adults.
    Abdul Shakoor SK; Shalet SM
    J Endocrinol Invest; 2003 Sep; 26(9):911-8. PubMed ID: 14964445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency confirmed after completion of growth promotion.
    Hilczer M; Smyczyńska J; Stawerska R; Lewiński A
    Endokrynol Pol; 2008; 59(4):292-300. PubMed ID: 18777498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
    Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of continuous and intermittent patterns of growth hormone administration on lipoprotein levels in growth hormone-deficient patients.
    Laursen T; Lemming L; Jørgensen JO; Klausen IC; Christiansen JS
    Horm Res; 1998; 50(5):284-91. PubMed ID: 9873197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Program of Severe Growth Hormone Deficiency Treatment in Adults and Adolescents after Completion of Growth Promoting Therapy.
    Lewiński A; Smyczyńska J; Stawerska R; Hilczer M; Stasiak M; Bednarczuk T; Bolanowski M; Junik R; Ruchała M; Syrenicz A; Walczak M; Zgliczyński W; Karbownik-Lewińska M
    Endokrynol Pol; 2018; 69(5):468-524. PubMed ID: 30117531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
    Çamtosun E; Şıklar Z; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):247-255. PubMed ID: 29553045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
    Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
    Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficiency: strategies and indications to continue growth hormone therapy in transition from adolescence to adult life.
    Leong GM; Johannsson G
    Horm Res; 2003; 60(Suppl 1):78-85. PubMed ID: 12955023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
    Gleeson H; Barreto ES; Salvatori R; Costa L; Oliveira CR; Pereira RM; Clayton P; Aguiar-Oliveira MH
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):466-74. PubMed ID: 17371461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for GH replacement in adolescents and young adults.
    Monson JP
    J Endocrinol Invest; 2005; 28(5 Suppl):52-5. PubMed ID: 16114277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults.
    Kohno H; Ueyama N; Honda S
    Diabetes Obes Metab; 1999 Sep; 1(5):293-6. PubMed ID: 11225641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.